Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
about
Cervical lymph node diseases in childrenGene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositisDeciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Muscle Metabolic Responses During Dynamic In-Magnet Exercise Testing: A Pilot Study in Children with an Idiopathic Inflammatory Myopathy.A genomic approach to human autoimmune diseases.HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese populationDeveloping a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research.Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathiesMycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.Interferon-α induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis.Acute acalculous cholecystitis in a patient with juvenile dermatomyositisThe Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.Design of the muscles in motion study: a randomized controlled trial to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositisHuman blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.DNA methylation dynamics in muscle development and disease.High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort.Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.Autoimmune neuromuscular disorders in childhoodOvarian teratoma mimicking features of juvenile dermatomyositis in a child.Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cellsChimeric cells of maternal origin do not appear to be pathogenic in the juvenile idiopathic inflammatory myopathies or muscular dystrophy.Juvenile dermatomyositis: new insights and new treatment strategies.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositisJuvenile dermatomyositis in pregnancyAdult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositisThe myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases.The PRINTO criteria for clinically inactive disease in juvenile dermatomyositisComparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study
P2860
Q26865114-CAC97A13-FD26-4414-AAE8-6E792655A990Q28287170-11A6CDA4-CF4E-4B17-A20F-6F3D9F13481AQ33717793-37745505-6076-47C8-BEF7-1EAAF534CE6BQ33740593-272291B6-2EB6-457F-A80C-66F1975AAA6BQ33762839-3A2E4317-109A-4CD6-AB13-DD5540B2F528Q33772990-46FFF697-E348-4B0F-BACE-520AE1D13360Q33962448-4400766D-0D4A-4241-9F60-A6838DEAA000Q33998204-09FD96DC-A488-4E7B-8397-1ED65904BEA0Q34074602-E1A123F8-CD5B-4705-868C-3B5C883BE654Q34185599-84D181DF-33B3-4675-A088-AE95160F84DBQ34214035-7781E59A-CC8E-4960-ABF0-94FE8EEA384AQ34220104-DE7626B1-00CB-4ED8-8543-ACBFE6530472Q34242363-8D507A2F-77D6-4D1E-9CE4-12F62349DC46Q34310736-93D72CB1-67AD-41B6-96B8-4E47AF9E60FEQ34312975-3CE84DAD-32C4-4D3B-92A9-95D359DBB3AEQ34615273-8C478C28-DAE3-4403-8BD8-509AC5875723Q35009335-374D3486-F894-4743-A246-E85FE7752A8EQ35149910-164B2E14-8A50-44AB-B336-DD237F229AC8Q35225827-890E37D1-0EB8-422D-BFC0-9CFBDABAB0BDQ35349884-4326BCC6-18E6-41ED-B940-33E02ACA0491Q35512273-AABB7B43-B750-46F1-B280-DC3942F9E64BQ35530037-70724861-8CCD-434A-B939-670C0674FF28Q35832819-0F5191EA-375B-44D9-89C1-7A901811601CQ35854122-3A75500B-C257-4F75-B6CF-F5D2A0FD39ADQ36022733-B6A3223D-444B-4062-BBC0-85DB1074FCB5Q36059542-290BDA04-3EE8-4C8D-8579-DE5B3B0939D9Q36086954-E934067A-C94D-401A-BDF1-D297A208A5C1Q36283423-46EBD2AC-8D91-414E-A9B6-0B4F158D3AB3Q36291269-A7EB7E63-FC48-4C9B-BA64-1D60CFF7CE47Q36794029-23FF6D88-87A7-4534-8D26-BE5BFF31107BQ36804956-CCEFF057-58A5-4FA8-AB3A-737482C96765Q36903076-64D52B20-C71E-44B2-8011-D6A074EDBDB1Q37023594-51558624-2037-46DE-A244-E0C7BF1EB22DQ37040711-9969B95E-D9FA-4426-BD1C-E7DEA617950AQ37229729-D71F4A8E-3A8C-4B5E-AC3D-989D30DDC839Q37254849-A3065491-2639-4C63-8F06-23868D0327EFQ37293030-AE62E5D0-BA74-46FF-909B-DDB2B464550CQ37316551-EB3E7FD8-E1F0-47F1-8890-DC0EA9AAFF12Q37372933-6A23EA0C-F876-42C4-AB5D-E5BCAF15BD0AQ37497903-BEF9D459-13E7-4284-88A2-D419633AF2BF
P2860
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@ast
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@en
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@nl
type
label
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@ast
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@en
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@nl
prefLabel
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@ast
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@en
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
@nl
P2093
P1433
P1476
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood
@en
P2093
Ann M Reed
Brian M Feldman
Lauren M Pachman
P304
P356
10.1016/S0140-6736(08)60955-1
P407
P577
2008-06-01T00:00:00Z